Frontiers in Immunology (May 2022)
Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors
- Athina Kilpeläinen,
- Athina Kilpeläinen,
- Esther Jimenez-Moyano,
- Oscar Blanch-Lombarte,
- Dan Ouchi,
- Ruth Peña,
- Bibiana Quirant-Sanchez,
- Bibiana Quirant-Sanchez,
- Bibiana Quirant-Sanchez,
- Raul Perez-Caballero,
- Anna Chamorro,
- Ignacio Blanco,
- Ignacio Blanco,
- Eva Martínez-Caceres,
- Eva Martínez-Caceres,
- Eva Martínez-Caceres,
- Roger Paredes,
- Roger Paredes,
- Roger Paredes,
- Roger Paredes,
- Lourdes Mateu,
- Lourdes Mateu,
- Jorge Carrillo,
- Jorge Carrillo,
- Jorge Carrillo,
- Julià Blanco,
- Julià Blanco,
- Julià Blanco,
- Julià Blanco,
- Christian Brander,
- Christian Brander,
- Christian Brander,
- Christian Brander,
- Christian Brander,
- Marta Massanella,
- Marta Massanella,
- Marta Massanella,
- Bonaventura Clotet,
- Bonaventura Clotet,
- Bonaventura Clotet,
- Bonaventura Clotet,
- Julia G. Prado,
- Julia G. Prado,
- Julia G. Prado
Affiliations
- Athina Kilpeläinen
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Athina Kilpeläinen
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
- Esther Jimenez-Moyano
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Oscar Blanch-Lombarte
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Dan Ouchi
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Ruth Peña
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Bibiana Quirant-Sanchez
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
- Bibiana Quirant-Sanchez
- Department of Cell Biology, Physiology, Immunology, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain
- Bibiana Quirant-Sanchez
- Immunology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
- Raul Perez-Caballero
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Anna Chamorro
- Lluita contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
- Ignacio Blanco
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
- Ignacio Blanco
- Clinical Genetics and Genetic Counseling Program, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
- Eva Martínez-Caceres
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
- Eva Martínez-Caceres
- Department of Cell Biology, Physiology, Immunology, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain
- Eva Martínez-Caceres
- Immunology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
- Roger Paredes
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Roger Paredes
- Lluita contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
- Roger Paredes
- Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
- Roger Paredes
- 0University of Vic–Central University of Catalonia (UVic-UCC), Vic, Catalonia, Spain
- Lourdes Mateu
- Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
- Lourdes Mateu
- 0University of Vic–Central University of Catalonia (UVic-UCC), Vic, Catalonia, Spain
- Jorge Carrillo
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Jorge Carrillo
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
- Jorge Carrillo
- CIBERINFEC, ISCIII, Madrid, Spain
- Julià Blanco
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Julià Blanco
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
- Julià Blanco
- CIBERINFEC, ISCIII, Madrid, Spain
- Julià Blanco
- 0University of Vic–Central University of Catalonia (UVic-UCC), Vic, Catalonia, Spain
- Christian Brander
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Christian Brander
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
- Christian Brander
- CIBERINFEC, ISCIII, Madrid, Spain
- Christian Brander
- ICREA, Barcelona, Spain
- Christian Brander
- 0University of Vic–Central University of Catalonia (UVic-UCC), Vic, Catalonia, Spain
- Marta Massanella
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Marta Massanella
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
- Marta Massanella
- CIBERINFEC, ISCIII, Madrid, Spain
- Bonaventura Clotet
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Bonaventura Clotet
- Lluita contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
- Bonaventura Clotet
- Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
- Bonaventura Clotet
- 0University of Vic–Central University of Catalonia (UVic-UCC), Vic, Catalonia, Spain
- Julia G. Prado
- IrsiCaixa AIDS Research Institute, Badalona, Spain
- Julia G. Prado
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
- Julia G. Prado
- CIBERINFEC, ISCIII, Madrid, Spain
- DOI
- https://doi.org/10.3389/fimmu.2022.815041
- Journal volume & issue
-
Vol. 13
Abstract
The role of T cells in the control of SARS-CoV-2 infection has been underestimated in favor of neutralizing antibodies. However, cellular immunity is essential for long-term viral control and protection from disease severity. To understand T-cell immunity in the absence of antibody generation we focused on a group of SARS-CoV-2 Non-Seroconvertors (NSC) recovered from infection. We performed an immune comparative analysis of SARS-CoV-2 infected individuals stratified by the absence or presence of seroconversion and disease severity. We report high levels of total naïve and low effector CD8+ T cells in NSC. Moreover, reduced levels of T-cell activation monitored by PD-1 and activation-induced markers were observed in the context of functional SARS-CoV-2 T-cell responses. Longitudinal data indicate the stability of the NSC phenotype over three months of follow-up after infection. Together, these data characterized distinctive immunological traits in NSC including skewed cellular distribution, low activation and functional SARS-CoV-2 T-cell responses. This data highlights the value of T-cell immune monitoring in populations with low seroconversion rates in response to SARS-CoV-2 infection and vaccination.
Keywords